Correlation Between Diamyd Medical and MagnaChip Semiconductor

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Diamyd Medical and MagnaChip Semiconductor at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Diamyd Medical and MagnaChip Semiconductor into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Diamyd Medical AB and MagnaChip Semiconductor Corp, you can compare the effects of market volatilities on Diamyd Medical and MagnaChip Semiconductor and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Diamyd Medical with a short position of MagnaChip Semiconductor. Check out your portfolio center. Please also check ongoing floating volatility patterns of Diamyd Medical and MagnaChip Semiconductor.

Diversification Opportunities for Diamyd Medical and MagnaChip Semiconductor

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between Diamyd and MagnaChip is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Diamyd Medical AB and MagnaChip Semiconductor Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MagnaChip Semiconductor and Diamyd Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Diamyd Medical AB are associated (or correlated) with MagnaChip Semiconductor. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MagnaChip Semiconductor has no effect on the direction of Diamyd Medical i.e., Diamyd Medical and MagnaChip Semiconductor go up and down completely randomly.

Pair Corralation between Diamyd Medical and MagnaChip Semiconductor

Assuming the 90 days horizon Diamyd Medical AB is expected to generate 1.89 times more return on investment than MagnaChip Semiconductor. However, Diamyd Medical is 1.89 times more volatile than MagnaChip Semiconductor Corp. It trades about 0.01 of its potential returns per unit of risk. MagnaChip Semiconductor Corp is currently generating about -0.19 per unit of risk. If you would invest  145.00  in Diamyd Medical AB on November 4, 2024 and sell it today you would earn a total of  0.00  from holding Diamyd Medical AB or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Diamyd Medical AB  vs.  MagnaChip Semiconductor Corp

 Performance 
       Timeline  
Diamyd Medical AB 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Diamyd Medical AB are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Diamyd Medical reported solid returns over the last few months and may actually be approaching a breakup point.
MagnaChip Semiconductor 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in MagnaChip Semiconductor Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, MagnaChip Semiconductor may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Diamyd Medical and MagnaChip Semiconductor Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Diamyd Medical and MagnaChip Semiconductor

The main advantage of trading using opposite Diamyd Medical and MagnaChip Semiconductor positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Diamyd Medical position performs unexpectedly, MagnaChip Semiconductor can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MagnaChip Semiconductor will offset losses from the drop in MagnaChip Semiconductor's long position.
The idea behind Diamyd Medical AB and MagnaChip Semiconductor Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments